A multicenter trial to test pitavastatin calcium in youth with combined dyslipidemia of obesity: Design, implementation, challenges, and responses

“Early lipid screening beginning at 9-11 years of age enables earlier identification of dyslipidemia, including familial hypercholesterolemia (FH), offering opportunity for intervention prior to accumulation of atherogenic exposure.”